HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
HLA-DRB5 |
HLA-DRB3: HLA class II histocompatibility antigen, DRB3-1 beta chain precursor |
1.18 |
Evidence |
|
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
MICB |
MICB: MHC class I polypeptide-related sequence B (Fragment) |
1.18 |
Evidence |
|
CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
CARD8 |
CARD8, KIAA0955, NDPP1: Caspase recruitment domain-containing protein 8 |
1.18 |
Evidence |
|
HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
MICB |
MICB: MHC class I polypeptide-related sequence B (Fragment) |
1.18 |
Evidence |
|
HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
HLA-DPA1 |
HLA-DPA1, HLA-DP1A, HLASB: HLA class II histocompatibility antigen, DP alpha cha |
1.18 |
Evidence |
|
BIRC2 |
BIRC2, API1, IAP2, MIHB, RNF48: Baculoviral IAP repeat-containing protein 2 |
CARD8 |
CARD8, KIAA0955, NDPP1: Caspase recruitment domain-containing protein 8 |
1.18 |
Evidence |
|
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
HLA-DRB5 |
HLA-Dw12: Cell surface glycoprotein |
1.18 |
Evidence |
|
PSMA1 |
PSMA1, PROS30, PSC2: Proteasome subunit alpha type-1 |
PSMB3 |
PSMB3: Proteasome subunit beta type-3 |
1.18 |
Evidence |
|
SNRPB |
SNRPB, COD, SNRPB1: Small nuclear ribonucleoprotein-associated proteins B and B' |
LSM3 |
LSM3, MDS017: U6 snRNA-associated Sm-like protein LSm3 |
1.18 |
Evidence |
|
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
MICB |
MICB: MHC class I polypeptide-related sequence B (Fragment) |
1.18 |
Evidence |
|
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
HLA-DRB5 |
HLA-Dw12: Cell surface glycoprotein |
1.18 |
Evidence |
|
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
FYN |
IPI00640091 |
1.18 |
Evidence |
|
SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
1.18 |
Evidence |
|
TMPRSS2 |
TMPRSS2, PRSS10: Transmembrane protease, serine 2 precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
1.177 |
Evidence |
|
SELE |
SELE, ELAM1: E-selectin precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
1.177 |
Evidence |
|
NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
CRKL |
CRKL: Crk-like protein |
1.177 |
Evidence |
|
APC |
IPI00215877 |
DSG2 |
DSG2: Desmoglein-2 precursor |
1.177 |
Evidence |
|
CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
USP34 |
USP34, KIAA0570, KIAA0729: Ubiquitin carboxyl-terminal hydrolase 34 |
1.177 |
Evidence |
|
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
STMN2 |
STMN2, SCG10, SCGN10: Stathmin-2 |
1.177 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
PHB2 |
PHB2, BAP, REA: Prohibitin-2 |
1.177 |
Evidence |
|
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
PTPRJ |
PTPRJ, DEP1: Receptor-type tyrosine-protein phosphatase eta precursor |
1.177 |
Evidence |
|
TP73 |
TP73, P73: Tumor protein p73 |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
1.177 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
SELE |
SELE, ELAM1: E-selectin precursor |
1.177 |
Evidence |
|
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
GPA33 |
GPA33: Cell surface A33 antigen precursor |
1.177 |
Evidence |
|
WASPIP |
IPI00552369 |
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
1.177 |
Evidence |
|